title: Effects of high adherence to mediterranean or low-fat diets in medicated secondary prevention patients.
abstract: Although the Mediterranean diet (MD) and the low-fat Therapeutic Lifestyle Changes Diet (TLCD) promote equivalent increases in event-free survival in secondary coronary prevention, possible mechanisms of such complete dietary patterns in these patients, usually medicated, are unclear. The aim of this study was to investigate the effects of the MD versus the TLCD in markers of endothelial function, oxidative stress, and inflammation after acute coronary syndromes. Comparison was made between 3 months of the MD (n = 21; rich in whole grains, vegetables, fruits, nuts, and olive oil, plus red wine) and the TLCD (n = 19; plus phytosterols 2 g/day) in a highly homogenous population of stable patients who experienced coronary events in the previous 2 years (aged 45 to 65 years, all men) allocated to each diet under a strategy designed to optimize adherence, documented as >90%. Baseline demographics, body mass index and clinical data, and use of statins and other drugs were similar between groups. The MD and TLCD promoted similar decreases in body mass index and blood pressure (p ≤0.001) and particularly in plasma asymmetric dimethylarginine levels (p = 0.02) and l-arginine/asymmetric dimethylarginine ratios (p = 0.01). The 2 diets did not further enhance flow-mediated brachial artery dilation compared to baseline (4.4 ± 4.0%). Compared to the TLCD, the MD promoted decreases in blood leukocyte count (p = 0.025) and increases in high-density lipoprotein levels (p = 0.053) and baseline brachial artery diameter. Compared to the MD, the TLCD decreased low-density lipoprotein and oxidized low-density lipoprotein plasma levels, although the ratio of oxidized to total low-density lipoprotein remained unaltered. Glucose, high-sensitivity C-reactive protein, triglycerides, myeloperoxidase, intercellular adhesion molecular, vascular cell adhesion molecule, and glutathione serum and plasma levels remained unchanged with either diet. In conclusion, medicated secondary prevention patients show evident although small responses to the MD and the TLCD, with improved markers of redox homeostasis and metabolic effects potentially related to atheroprotection.
authors: Vascular Biology Laboratory, University of São Paulo School of Medicine, Brazil.
authors: Maria Cristina D
authors: MC
authors: Thomazella
authors: Marisa F S
authors: MF
authors: Góes
authors: Cláudia R
authors: CR
authors: Andrade
authors: Victor
authors: V
authors: Debbas
authors: Denise F
authors: DF
authors: Barbeiro
authors: Renata L
authors: RL
authors: Correia
authors: Sueli K N
authors: SK
authors: Marie
authors: Arturo J
authors: AJ
authors: Cardounel
authors: Protásio L
authors: PL
authors: daLuz
authors: Francisco R M
authors: FR
authors: Laurindo
mesh_terms: D000368:Aged; D050197:Atherosclerosis / Q000097:blood / Q000517:prevention & control*; D015415:Biomarkers / Q000097:blood*; D002097:C-Reactive Protein / Q000378:metabolism; D018752:Diet, Fat-Restricted; D038441:Diet, Mediterranean; D005500:Follow-Up Studies; D006801:Humans; D007249:Inflammation / Q000097:blood*; D008019:Life Style; D008077:Lipoproteins, LDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D011379:Prognosis; D011446:Prospective Studies; D055502:Secondary Prevention / Q000379:methods*; D014280:Triglycerides / Q000097:blood
chemical_list: D015415:Biomarkers; D008077:Lipoproteins, LDL; D014280:Triglycerides; C099252:oxidized low density lipoprotein; D002097:C-Reactive Protein